Related Experiment Video
Updated: Jun 28, 2026
08:06
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
Published on: January 31, 2025
[Prevention and multimodal therapy of hyperthyroidism]
1Klinik für Endokrinologie, Diabetologie, Angiologie und Innere Medizin, Klinikum Neuperlach, Städtisches Klinikum München GmbH, München, Deutschland. kd.palitzsch@kh-neuperlach.de
Der Internist
|October 24, 2008
Summary
Hyperthyroidism, or overactive thyroid, increases risks like atrial fibrillation and cardiovascular death, particularly in older adults. Avoiding iodine and unnecessary TSH suppressive therapy can help prevent this condition.
Area of Science:
- Endocrinology
- Cardiology
Context:
- Subclinical and overt hyperthyroidism are linked to adverse outcomes, including atrial fibrillation and cardiovascular mortality, especially in the elderly.
- Iodine-containing medications and contrast agents can precipitate hyperthyroidism.
Purpose:
- To review the clinical outcomes associated with hyperthyroidism and provide recommendations for its prevention and management.
- To highlight the risks of TSH suppressive therapy in endemic goiter and differentiated thyroid carcinoma.
Summary:
- Hyperthyroidism is associated with significant health risks, particularly in older individuals.
- Preventive measures include judicious use of iodine and contrast agents.
- TSH suppressive therapy is generally not recommended for endemic goiter or low-risk thyroid cancer due to the risk of inducing hyperthyroidism.
- Overt hyperthyroidism management depends on the underlying cause, utilizing antithyroid drugs, radioiodine, or surgery.
Impact:
- Informing clinical practice to reduce hyperthyroidism incidence and associated complications.
- Guiding therapeutic decisions regarding TSH suppressive therapy and overt hyperthyroidism treatment.
- Improving patient outcomes by mitigating risks of atrial fibrillation and cardiovascular mortality.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...